I honestly can’t be arsed to retort to everythin
Post# of 148166
Price started moving back up before EG conference (and news of POs).
NASH and cancer news isn’t new. We knew these catalysts were coming. The mTNBC PR didn’t budge the pps at all when released.
Brazil confirmation of first patient started this move, all the things you list are supporting and reinforcing it. I never used the term “undervalued” but I did argue you were wrong saying Brazil was “priced in” at $1.30.
Breaking news: you were wrong.